| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,695,900 | 1,695,100 | 1,772,300 | 1,849,300 | | Cost of Revenue | 1,180,100 | 1,191,000 | 1,214,900 | 1,286,900 | | | Gross Profit | 515,800 | 504,100 | 557,400 | 562,400 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 248,000 | 263,000 | 260,600 | 273,900 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 267,800 | 241,100 | 296,800 | 288,500 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,800) | 8,200 | 4,100 | (11,400) | | Earnings Before Interest And Taxes | 264,000 | 246,300 | 288,600 | 280,800 | | Interest Expense | 28,800 | 27,200 | 26,700 | 27,700 | | Income Before Tax | 235,200 | 219,100 | 261,900 | 253,100 | | Income Tax Expense | 61,900 | 50,500 | 94,100 | 69,500 | | Minority Interest |
-
| (3,000) | (12,300) | 3,700 | | | | Net Income From Continuing Ops | 173,300 | 168,600 | 167,800 | 183,600 | | | Non-recurring Events | | Discontinued Operations | 500 | 100 | 200 | 3,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 173,800 | 168,700 | 168,000 | 186,600 | | Preferred Stock And Other Adjustments | (4,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $169,800 | $168,700 | $168,000 | $186,600 |
|
0.45% Nasdaq 
0.20%
Income Statement
